Yu Huang

Dr. Yu Huang

Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China
+1

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 1989 in Science
Verified
Journal Article
Closed access
PDF file
NSNicholas B. Standen
Nicholas B. Standen
JQJohn M. Quayle
John M. Quayle
NDNoel W. Davies
Noel W. Davies
JBJoseph E. Brayden
Joseph E. Brayden
Yu HuangYu Huang
Yu Huang
MNMark T. Nelson
Mark T. Nelson
Vasodilators are used clinically for the treatment of hypertension and heart failure. The effects of some vasodilators seem to be mediated by membrane hyperpolarization. The molecular basis of this hyperpolarization has been investigated by examining the properties of single K + channels in arterial smooth muscle cells. The presence of adenosine triphosphate (ATP)-sensitive K + channels in these cells was demonstrated at the single channel level. These channels were opened by the hyperpolarizing vasodilator cromakalim and inhibited by the ATP-sensitive K + channel blocker glibenclamide. Furthermore, in arterial rings the vasorelaxing actions of the drugs diazoxide, cromakalim, and pinacidil and the hyperpolarizing actions of vasoactive intestinal polypeptide and acetylcholine were blocked by inhibitors of the ATP-sensitive K + channel, suggesting that all these agents may act through a common pathway in smooth muscle by opening ATP-sensitive K + channels.

1 June 2018 in CATENA
Verified
Journal Article
Closed access
Yu HuangYu Huang
Yu Huang
LZLu Zhao
Lu Zhao

7 December 2016 in Nature
Verified
Journal Article
Closed access
LWLi Wang
Li Wang
JLJiang-Yun Luo
Jiang-Yun Luo
BLBochuan Li
Bochuan Li
XTXiao Yu Tian
Xiao Yu Tian
LCLi-Jing Chen
Li-Jing Chen
Yu HuangYu Huang
Yu Huang

20 December 2000 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
ZCZhenyu Chen
Zhenyu Chen
QZQin Yan Zhu
Qin Yan Zhu
DTDavid Tsang
David Tsang
Yu HuangYu Huang
Yu Huang

1 September 2001 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
LLLai Kwok Leung
Lai Kwok Leung
YSYalun Su
Yalun Su
ZZZesheng Zhang
Zesheng Zhang
ZCZhenyu Chen
Zhenyu Chen
Yu HuangYu Huang
Yu Huang
RCRuoyun Chen
Ruoyun Chen
Green tea catechins, including (-)-epicatechin (EC), (-)-epicatechin gallate (ECG), (-)-epigallocatechin (EGC) and (-)-epigallocatechin gallate (EGCG), are oxidized and dimerized during the manufacture of black tea and oolong tea to form orange-red pigments, theaflavins (TF), a mixture of theaflavin (TF1), theaflavin-3-gallate (TF2A), theaflavin-3′-gallate (TF2B) and theaflavin-3,3′-digallate (TF3). The present study was designed to compare the antioxidant activities of individual TF with that of each catechin using human LDL oxidation as a model. All catechins and TF tested inhibited Cu+2-mediated LDL oxidation. Analysis of the thiobarbituric acid–reactive substances (TBARS) and conjugated dienes produced during LDL oxidation revealed that the antioxidant activity was in the order: TF3 > ECG > EGCG ≥ TF2B ≥ TF2A > TF1 ≥ EC > EGC. Four TF derivatives also demonstrated a dose-dependent antioxidant activity in Cu+2-mediated LDL oxidation at concentrations of 5–40 μmol/L. These results demonstrate that the TF present in black tea possess at least the same antioxidant potency as catechins present in green tea, and that the conversion of catechins to TF during fermentation in making black tea does not alter significantly their free radical–scavenging activity.

1 April 1990 in Nature
Verified
Journal Article
Closed access
MNMark T. Nelson
Mark T. Nelson
Yu HuangYu Huang
Yu Huang
JBJoseph E. Brayden
Joseph E. Brayden
JHJürgen Hescheler
Jürgen Hescheler
NSNicholas B. Standen
Nicholas B. Standen